157 related articles for article (PubMed ID: 38468681)
1. Adjuvant proton beam therapy in patients with grade 2 meningiomas.
Wilson TA; Kang JI; Huang L; Vacaru A; Martins KN; Boling WW
Surg Neurol Int; 2024; 15():62. PubMed ID: 38468681
[TBL] [Abstract][Full Text] [Related]
2. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
[TBL] [Abstract][Full Text] [Related]
3. The role of proton beam therapy in central neurocytoma: A single-institution experience.
Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
6. Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity.
Ravindra VM; Okcu MF; Ruggieri L; Frank TS; Paulino AC; McGovern SL; Horne VE; Dauser RC; Whitehead WE; Aldave G
J Neurosurg Pediatr; 2021 May; 28(2):152-159. PubMed ID: 34049281
[TBL] [Abstract][Full Text] [Related]
7. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
8. Atypical meningiomas: is postoperative radiotherapy indicated?
Lee KD; DePowell JJ; Air EL; Dwivedi AK; Kendler A; McPherson CM
Neurosurg Focus; 2013 Dec; 35(6):E15. PubMed ID: 24289123
[TBL] [Abstract][Full Text] [Related]
9. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas.
Vlachogiannis P; Gudjonsson O; Montelius A; Grusell E; Isacsson U; Nilsson K; Blomquist E
Acta Neurochir (Wien); 2017 Dec; 159(12):2391-2400. PubMed ID: 29064038
[TBL] [Abstract][Full Text] [Related]
11. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
12. Survival and Recurrence Outcomes Following Adjuvant Radiotherapy for Grade 2 Intracranial Meningiomas: 13-Year Experience in a Tertiary-Care Center.
Rebchuk AD; Alam A; Hounjet CD; Chaharyn BM; Gooderham PA; Yip S; Ma RMK; Nichol A; Makarenko S
World Neurosurg; 2022 May; 161():e748-e756. PubMed ID: 35240308
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiation versus observation with salvage radiation after gross-total resection of WHO grade II meningiomas: a propensity score-adjusted analysis.
Momin AA; Soni P; Shao J; Nowacki AS; Suh JH; Murphy ES; Chao ST; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
J Neurosurg; 2022 Jun; 136(6):1517-1524. PubMed ID: 34624866
[TBL] [Abstract][Full Text] [Related]
15. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
[TBL] [Abstract][Full Text] [Related]
16. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
18. Beyond the Surgical Margin: Patterns of Recurrence in World Health Organization Grade 2 Intracranial Meningiomas.
Obiri-Yeboah D; Soni P; Oyem PC; Almeida JP; Murayi R; Recinos PF; Kshettry VR
World Neurosurg; 2023 Jun; ():. PubMed ID: 37390903
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sun SQ; Hawasli AH; Huang J; Chicoine MR; Kim AH
Neurosurg Focus; 2015 Mar; 38(3):E3. PubMed ID: 25727225
[TBL] [Abstract][Full Text] [Related]
20. Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
Jazmati D; Butzer S; Hero B; Ahmad Khalil D; Merta J; Bäumer C; Plum G; Fuchs J; Koerber F; Steinmeier T; Peters S; Doyen J; Thole T; Schmidt M; Blase C; Tippelt S; Eggert A; Schwarz R; Simon T; Timmermann B
Front Oncol; 2020; 10():617506. PubMed ID: 33552991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
